Some recent prospective studies have confirmed that circulating NGAL levels are independently associated with long-term CHD outcomes in older women and significantly associated with all-cause mortality during long-term follow-up in ACS patients [32, 33]. Here, LCN2 is linked to coronary artery disorder.